[go: up one dir, main page]

DE602004027476D1 - Zusammensetzungen und formulierungsverfahren für enteralprodukte, die sialsäure enthalten - Google Patents

Zusammensetzungen und formulierungsverfahren für enteralprodukte, die sialsäure enthalten

Info

Publication number
DE602004027476D1
DE602004027476D1 DE602004027476T DE602004027476T DE602004027476D1 DE 602004027476 D1 DE602004027476 D1 DE 602004027476D1 DE 602004027476 T DE602004027476 T DE 602004027476T DE 602004027476 T DE602004027476 T DE 602004027476T DE 602004027476 D1 DE602004027476 D1 DE 602004027476D1
Authority
DE
Germany
Prior art keywords
compositions
sialic acid
products containing
formulation process
containing sialic
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
DE602004027476T
Other languages
English (en)
Inventor
Robert J Mcmahon
Mary Frances Locniskar
Steven Charles Rumsey
Joshua C Anthony
Ratchapong Wungtanagorn
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Mead Johnson Nutrition Co
Original Assignee
Mead Johnson Nutrition Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Mead Johnson Nutrition Co filed Critical Mead Johnson Nutrition Co
Publication of DE602004027476D1 publication Critical patent/DE602004027476D1/de
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • AHUMAN NECESSITIES
    • A23FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23CDAIRY PRODUCTS, e.g. MILK, BUTTER OR CHEESE; MILK OR CHEESE SUBSTITUTES; MAKING OR TREATMENT THEREOF
    • A23C9/00Milk preparations; Milk powder or milk powder preparations
    • A23C9/16Agglomerating or granulating milk powder; Making instant milk powder; Products obtained thereby
    • AHUMAN NECESSITIES
    • A23FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23CDAIRY PRODUCTS, e.g. MILK, BUTTER OR CHEESE; MILK OR CHEESE SUBSTITUTES; MAKING OR TREATMENT THEREOF
    • A23C9/00Milk preparations; Milk powder or milk powder preparations
    • A23C9/20Dietetic milk products not covered by groups A23C9/12 - A23C9/18
    • AHUMAN NECESSITIES
    • A23FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23CDAIRY PRODUCTS, e.g. MILK, BUTTER OR CHEESE; MILK OR CHEESE SUBSTITUTES; MAKING OR TREATMENT THEREOF
    • A23C9/00Milk preparations; Milk powder or milk powder preparations
    • A23C9/12Fermented milk preparations; Treatment using microorganisms or enzymes
    • A23C9/13Fermented milk preparations; Treatment using microorganisms or enzymes using additives
    • A23C9/1307Milk products or derivatives; Fruit or vegetable juices; Sugars, sugar alcohols, sweeteners; Oligosaccharides; Organic acids or salts thereof or acidifying agents; Flavours, dyes or pigments; Inert or aerosol gases; Carbonation methods
    • AHUMAN NECESSITIES
    • A23FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23LFOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
    • A23L33/00Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/10Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
    • A23L33/17Amino acids, peptides or proteins
    • A23L33/19Dairy proteins
    • AHUMAN NECESSITIES
    • A23FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23LFOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
    • A23L33/00Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/40Complete food formulations for specific consumer groups or specific purposes, e.g. infant formula
    • AHUMAN NECESSITIES
    • A23FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23VINDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
    • A23V2002/00Food compositions, function of food ingredients or processes for food or foodstuffs

Landscapes

  • Life Sciences & Earth Sciences (AREA)
  • Food Science & Technology (AREA)
  • Polymers & Plastics (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Health & Medical Sciences (AREA)
  • Nutrition Science (AREA)
  • Mycology (AREA)
  • Pediatric Medicine (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Microbiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Coloring Foods And Improving Nutritive Qualities (AREA)
  • Dairy Products (AREA)
DE602004027476T 2003-04-14 2004-03-19 Zusammensetzungen und formulierungsverfahren für enteralprodukte, die sialsäure enthalten Expired - Lifetime DE602004027476D1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US10/413,508 US7867541B2 (en) 2003-04-14 2003-04-14 Compositions and methods of formulation for enteral formulas containing sialic acid
PCT/US2004/008451 WO2004093557A1 (en) 2003-04-14 2004-03-19 Compositions and methods of formulation for enteral formulas containing sialic acid

Publications (1)

Publication Number Publication Date
DE602004027476D1 true DE602004027476D1 (de) 2010-07-15

Family

ID=33131416

Family Applications (1)

Application Number Title Priority Date Filing Date
DE602004027476T Expired - Lifetime DE602004027476D1 (de) 2003-04-14 2004-03-19 Zusammensetzungen und formulierungsverfahren für enteralprodukte, die sialsäure enthalten

Country Status (21)

Country Link
US (1) US7867541B2 (de)
EP (1) EP1613169B1 (de)
KR (1) KR101087332B1 (de)
CN (1) CN100515216C (de)
AR (1) AR043846A1 (de)
AT (1) ATE469560T1 (de)
BR (1) BRPI0409309B1 (de)
CA (1) CA2522091C (de)
CL (1) CL2004000803A1 (de)
DE (1) DE602004027476D1 (de)
DK (1) DK1613169T3 (de)
EC (1) ECSP056101A (de)
ES (1) ES2346533T3 (de)
MX (1) MXPA05010806A (de)
MY (1) MY154371A (de)
NO (1) NO330441B1 (de)
PL (1) PL1613169T3 (de)
PT (1) PT1613169E (de)
RU (1) RU2361408C2 (de)
TW (1) TWI369183B (de)
WO (1) WO2004093557A1 (de)

Families Citing this family (74)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DK0951842T3 (da) * 1999-01-20 2003-01-06 Nutricia Nv Ernæringsprodukt til et spædbarn
EP1342071A1 (de) * 2000-12-13 2003-09-10 Institut d'Optique Theorique et appliquee Verfahren zur charakterisierung einer oberfläche und einrichtung dafür
US20100268658A1 (en) * 2001-05-14 2010-10-21 Prolacta Bioscience Method for collecting, testing and distributing milk
US7951410B2 (en) * 2003-04-14 2011-05-31 Mead Johnson Nutrition Company Enteral compositions containing caseinoglycomacropeptide having an enhanced concentration of sialic acid
DE102004040452A1 (de) * 2004-08-20 2006-02-23 N.V. Nutricia Peptidgemisch
ES2587338T3 (es) * 2004-10-12 2016-10-24 Fonterra Co-Operative Group Limited Productos lácteos de beta-suero, productos lácteos con depleción de lípidos neutros y/o enriquecidos en lípidos polares y procesos para su producción
US20060247153A1 (en) * 2005-04-29 2006-11-02 Mcmahon Robert J Method of improving learning and memory in mammals
US20060246146A1 (en) * 2005-04-29 2006-11-02 Mcmahon Robert J Method of increasing the salivary sialic acid content in a mammal
NZ563659A (en) 2005-05-23 2011-05-27 Massachusetts Inst Technology Use of compositions containing omega 3 or 6 fatty acids and either uridine or choline for treating Alzheimer's and other memory disorders
WO2007035870A2 (en) 2005-09-20 2007-03-29 Prolacta Bioscience, Inc. A method for testing milk
US7829126B2 (en) * 2005-10-26 2010-11-09 Abbott Laboratories Infant formulas containing docosahexaenoic acid and lutein
BRPI0618261A2 (pt) * 2005-11-04 2011-08-23 Arla Foods Amba concentrado e composição derivados de um produto de leite enriquecido em sialil-lactose que ocorre naturalmente, processo para preparação dos mesmos e produto
ES2584191T3 (es) * 2005-11-30 2016-09-26 Vegenat, S.A. Mezcla de proteínas y su utilización para preparar un producto destinado a la alimentación oral o enteral
ES2366034T3 (es) * 2005-12-23 2011-10-14 N.V. Nutricia Composición que comprende ácidos grasos poliinsaturados, proteínas, manganeso y/o molibdeno y nucleósidos/nucleótidos para el tratamiento de la demencia.
US20080003330A1 (en) * 2006-06-30 2008-01-03 Ricardo Rueda Infant formulas for early brain development
WO2008067486A2 (en) * 2006-11-29 2008-06-05 Prolacta Bioscience, Inc. Human milk compositions and methods of making and using same
JP5616066B2 (ja) * 2006-12-08 2014-10-29 プロラクタ バイオサイエンス,インコーポレイテッド ヒト脂質組成物ならびにその製造および使用方法
US20100196539A1 (en) * 2007-06-25 2010-08-05 Albertus Alard Van Dijk Novel prebiotics
ES2377565T3 (es) * 2007-09-17 2012-03-28 N.V. Nutricia Formulación nutricional con alto contenido energético
EP3763219A1 (de) * 2007-10-19 2021-01-13 Fonterra Co-Operative Group Limited Verfahren zur aufrechterhaltung oder steigerung des wachstums oder der kognitiven entwicklung
EP2096115A1 (de) * 2008-02-26 2009-09-02 Nestec S.A. Oligosaccharid-Inhaltsstoff
KR101116864B1 (ko) * 2008-08-01 2012-02-29 주식회사 베네비오 고지혈증, 지방간 또는 비만의 예방 또는 치료용 조성물
ES2378854T3 (es) 2008-11-10 2012-04-18 Nestec S.A. Bacterias que producen ácido siálico
ES2527959T3 (es) 2008-12-02 2015-02-02 Prolacta Bioscience, Inc. Composiciones de permeado de leche humana y métodos para realizarlas y usarlas
US8293264B2 (en) * 2009-05-11 2012-10-23 Mead Johnson Nutrition Company Nutritional composition to promote healthy development and growth
KR101158472B1 (ko) * 2009-11-05 2012-06-20 주식회사 베네비오 알코올에 유발된 간질환의 예방 또는 치료용 조성물
CA2792112C (en) * 2010-03-12 2018-09-04 Dsm Ip Assets B.V. Maternal sialic acid supplementation
EP2554057A4 (de) * 2010-03-31 2013-12-18 Vegenat S A Enterale oder orale nahrungsmittelprodukte, im besonderen zur ernährung und prävention sowie verbesserung von neurologischen erkrankungen, neurodegenerativen erkrankungen oder kognitiven störungen
EP2554058A4 (de) * 2010-03-31 2013-12-25 Vegenat S A Funktionelle nahrungsergänzung, im besonderen zur ernährung und prävention sowie verbesserung von neurologischen erkrankungen, neurodegenerativen erkrankungen oder kognitiven störungen
EP2658399B2 (de) 2010-12-31 2024-02-28 Abbott Laboratories Nährstoffzusammensetzungen mit oligosacchariden aus menschlicher milch und nukleotiden zur verwendung zur behandlung und/oder prävention von enteralen rotavirusinfektionen
SG191392A1 (en) 2010-12-31 2013-08-30 Abbott Lab Methods for decreasing the incidence of necrotizing enterocolitis in infants, toddlers, or children using human milk oligosaccharides
PH12013501361A1 (en) 2010-12-31 2013-09-16 Abbott Lab Human milk oligosaccharides for modulating inflammation
WO2012092157A2 (en) 2010-12-31 2012-07-05 Abbott Laboratories Nutritional formulations including human milk oligosaccharides and antioxidants and uses thereof
CN103379908B (zh) 2010-12-31 2020-02-14 雅培制药有限公司 使用人乳寡糖、维生素c和抗炎剂减少氧化应激的发病率的方法
EP3473257A1 (de) 2010-12-31 2019-04-24 Abbott Laboratories Verfahren zur verwendung menschlicher milcholigosaccharide zur verbesserung des gesundheitszustandes der atemwege
CN108741083A (zh) 2010-12-31 2018-11-06 雅培制药有限公司 促进有益细菌生长的中性人乳寡糖
PT2672844E (pt) 2011-02-10 2015-02-04 Nestec Sa Modulação do crescimento de bifidobactérias utilizando uma combinação de oligossacáridos identificados no leite humano
EP2730646B2 (de) 2011-06-30 2020-01-22 Chr. Hansen A/S Trocknen von Milchsäurebakterien und neuartige Zusammensetzungen
US8183227B1 (en) 2011-07-07 2012-05-22 Chemo S. A. France Compositions, kits and methods for nutrition supplementation
WO2013016111A1 (en) 2011-07-22 2013-01-31 Abbott Laboratories Galactooligosaccharides for preventing injury and/or promoting healing of the gastrointestinal tract
CA2844045C (en) 2011-08-03 2018-05-08 Prolacta Bioscience, Inc. Microfiltration of human milk to reduce bacterial contamination
CN104023560A (zh) 2011-08-29 2014-09-03 雅培制药有限公司 用于预防胃肠道损伤和/或促进胃肠道愈合的人乳寡糖
US8168611B1 (en) 2011-09-29 2012-05-01 Chemo S.A. France Compositions, kits and methods for nutrition supplementation
US20140179782A1 (en) * 2011-10-14 2014-06-26 Mead Johnson Nutrition Company Neurogenesis screening method and uses thereof
PL2790522T3 (pl) 2011-12-14 2015-10-30 Nestec Sa Zemulgowany produkt spożywczy zawierający mleczne białko
US20140179775A1 (en) * 2012-02-29 2014-06-26 Mead Johnson Nutrition Company Neurogenesis screening method and uses thereof
US9351978B2 (en) * 2012-02-29 2016-05-31 Mead Johnson Nutrition Company Neurogenesis screening method and uses thereof
NZ630210A (en) 2012-03-14 2016-05-27 Abbott Lab Nutritional compositions including rrr -alpha tocopherol and polyunsaturated fatty acids
SE536599C3 (sv) 2012-04-10 2017-01-10 Hero Ag Näringssammansättning med lågt kalori- och lågt proteininnehåll
BR112015020568A2 (pt) 2013-03-13 2017-07-18 Abbott Lab composição para melhorar o desenvolvimento cognitivo, cerebral e/ou do snc do recém-nascido e método para o uso da mesma
EP3821713B1 (de) 2013-03-13 2025-01-01 Prolacta Bioscience, Inc. Menschliche milchprodukte mit hohem fettgehalt
MY169122A (en) 2013-03-13 2019-02-18 Abbott Lab Infant nutritional product with rrr alpha-tocopherol
CN103478251B (zh) * 2013-07-23 2015-03-25 东北农业大学 一种含唾液酸婴儿配方奶粉的制备方法
CN104187742A (zh) * 2014-07-09 2014-12-10 上海育生堂科技有限公司 一种用于促进青少年儿童成长和改善大脑发育的食用组合物
RU2761533C2 (ru) 2014-09-25 2021-12-09 Сосьете Де Продюи Нестле С.А. Система детской смеси с адаптивными концентрациями олигосахаридов грудного молока (огм)
WO2016145628A1 (en) 2015-03-18 2016-09-22 Nestec S.A. Composition comprising siallyllactose for use in enhancing learning skills and memory function
US10525016B2 (en) 2015-06-03 2020-01-07 Mead Johnson Nutrition Company Nutritional compositions containing an elevated level of inositol and uses thereof
US10582714B2 (en) 2015-07-10 2020-03-10 Mead Johnson Nutrition Company Nutritional compositions and methods for promoting cognitive development
US20170006897A1 (en) 2015-07-10 2017-01-12 Mead Johnson Nutrition Company Nutritional compositions and methods for promoting cognitive development
US10034937B2 (en) 2015-12-04 2018-07-31 Mead Johnson Nutrition Company Synergistic nutritional compositions and uses thereof
US11478011B2 (en) * 2015-12-14 2022-10-25 Societe Des Produits Nestle S.A. Nutritional compositions and infant formula for promoting de novo myealination
WO2017117409A1 (en) 2015-12-30 2017-07-06 Prolacta Bioscience, Inc. Human milk products useful in pre- and post-operative care
CN106615146A (zh) * 2016-09-01 2017-05-10 西安银桥乳业(集团)有限公司 一种添加组合益生元的婴幼儿配方奶粉及其制备方法
US20180161292A1 (en) 2016-12-12 2018-06-14 Mead Johnson Nutrition Company Nutritional compositions containing butyrate and uses thereof
US20180160714A1 (en) 2016-12-12 2018-06-14 Mead Johnson Nutrition Company Nutritional compositions containing butyrate and uses thereof
US20180168215A1 (en) 2016-12-21 2018-06-21 Mead Johnson Nutrition Company Nutritional compositions containing inositol and uses thereof
US20180332881A1 (en) 2017-05-17 2018-11-22 Mead Johnson Nutrition Company Preterm infant formula containing butyrate and uses thereof
CN107467667B (zh) * 2017-07-17 2018-06-26 北京亦贝安生物医药科技有限公司 一种含有两种不饱和脂肪酸和唾液酸的复方制剂
EP3473644A1 (de) * 2017-10-17 2019-04-24 Jennewein Biotechnologie GmbH Fermentative herstellung von n-acetylneuraminsäure
US20190208807A1 (en) 2018-01-05 2019-07-11 Mead Johnson Nutrition Company Nutritional compositions containing milk-derived peptides and uses thereof
GB2573538B (en) 2018-05-09 2023-01-04 Mjn Us Holdings Llc Pediatric nutritional compositions and methods for infants delivered by C-section
TW202126317A (zh) 2019-09-24 2021-07-16 美商普拉塔生技公司 用於治療發炎和免疫疾病之組成物和方法
CN111011522A (zh) * 2020-02-27 2020-04-17 青岛索康食品有限公司 一种提高免疫力的儿童配方奶粉及其制备方法
CN113068747A (zh) * 2020-03-24 2021-07-06 北京三元食品股份有限公司 一种促进孕产妇和婴幼儿健康的孕产妇配方乳粉

Family Cites Families (20)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4762822A (en) * 1985-08-08 1988-08-09 Ettinger Anna C Reduction of gastrointestinal disease-producing organisms with sialic acid and gangliosides
DD273543A3 (de) * 1987-09-14 1989-11-22 Univ Rostock Verfahren zur herstellung von saeuglings- und diaetnahrungen mit hypoantigener, bifidogener wirkung
ES2053627T3 (es) * 1988-07-07 1994-08-01 Milupa Ag Procedimiento para la preparacion de un alimento bifidogeno dietetico y para lactantes.
US6020015A (en) * 1988-09-22 2000-02-01 Gaull; Gerald E. Infant formula compositions and nutrition containing genetically engineered human milk proteins
WO1991016449A1 (en) * 1990-04-16 1991-10-31 The Trustees Of The University Of Pennsylvania Saccharide compositions, methods and apparatus for their synthesis
CH681543A5 (de) * 1990-04-27 1993-04-15 Nestle Sa
JP3035833B2 (ja) * 1991-01-21 2000-04-24 雪印乳業株式会社 シアル酸類含有組成物の製造方法
JP3125451B2 (ja) * 1991-11-05 2001-01-15 ソニー株式会社 信号処理方法
JPH07277929A (ja) 1994-04-01 1995-10-24 Momotani Jiyuntenkan:Kk 育毛、養毛料
US5576300A (en) * 1994-09-16 1996-11-19 Abbott Laboratories Method for inhibition of human rotavirus infection
US5575916A (en) * 1994-11-07 1996-11-19 Neose Pharmaceuticals, Inc. Method of processing a cheese processing waste stream
US5849324A (en) * 1995-07-10 1998-12-15 Abbott Laboratories Use of indigestible oligosaccharides to reduce the incidence of otitis media in humans
CA2262365A1 (en) 1996-08-30 1998-03-05 Societe Des Produits Nestle S.A. Nutritional formula for phenylketonuria patients
ATE230935T1 (de) * 1997-07-22 2003-02-15 Nestle Sa Lipidzusammensetzung für säuglingsnährpräparat und herstellungsverfahren
US6168823B1 (en) * 1997-10-09 2001-01-02 Wisconsin Alumni Research Foundation Production of substantially pure kappa casein macropeptide
DE69926990T2 (de) 1999-04-29 2006-06-08 Société des Produits Nestlé S.A. Süssmolkeprotein enthaltende Säuglingsnahrung
US6288222B1 (en) * 2000-02-16 2001-09-11 Neose Technologies, Inc. Method of filtration of a dairy stream
WO2001060346A2 (en) 2000-02-17 2001-08-23 Wyeth Nutritional formulation containing prebiotic substances
US6592863B2 (en) * 2000-08-22 2003-07-15 Nestec S.A. Nutritional composition
GB0116509D0 (en) 2001-07-06 2001-08-29 Hannah Res Inst The Methods of extracting casein fractions from milk and caseinates and production of novel products

Also Published As

Publication number Publication date
US20040202765A1 (en) 2004-10-14
ECSP056101A (es) 2006-03-01
NO20055335D0 (no) 2005-11-11
KR101087332B1 (ko) 2011-11-25
ES2346533T3 (es) 2010-10-18
TWI369183B (en) 2012-08-01
CN1802094A (zh) 2006-07-12
BRPI0409309B1 (pt) 2020-09-15
NO330441B1 (no) 2011-04-11
DK1613169T3 (da) 2010-09-20
MXPA05010806A (es) 2005-12-05
ATE469560T1 (de) 2010-06-15
NO20055335L (no) 2006-01-03
EP1613169A1 (de) 2006-01-11
HK1091376A1 (zh) 2007-01-19
CA2522091A1 (en) 2004-11-04
RU2005135122A (ru) 2006-03-10
KR20060006921A (ko) 2006-01-20
WO2004093557A1 (en) 2004-11-04
MY154371A (en) 2015-06-15
AR043846A1 (es) 2005-08-17
RU2361408C2 (ru) 2009-07-20
PT1613169E (pt) 2010-06-17
TW200503631A (en) 2005-02-01
BRPI0409309A (pt) 2006-04-18
CA2522091C (en) 2011-10-11
EP1613169B1 (de) 2010-06-02
PL1613169T3 (pl) 2010-11-30
US7867541B2 (en) 2011-01-11
CN100515216C (zh) 2009-07-22
CL2004000803A1 (es) 2005-05-06

Similar Documents

Publication Publication Date Title
DE602004027476D1 (de) Zusammensetzungen und formulierungsverfahren für enteralprodukte, die sialsäure enthalten
MY142029A (en) Phenoxyacetic acid derivatives
ATE473976T1 (de) Dipeptidylpeptidase-iv-inhibierende verbindungen, verfahren zu deren herstellung und pharmazeutische zusammensetzungen, die diese als wirkstoffe enthalten
ATE386017T1 (de) Carbonsäureamid substituierte phenylharnstoffderivate, verfahren zu ihrer herstellung als arzneimittel
DE60332760D1 (de) Zusammensetzungen für die ernährung
HUP0401241A3 (en) Novel cyclohexyl sulphones, process for their preparation and pharmaceutical compositions containing them
HUP0201646A3 (en) Novel alpha-amino acid derivatives, process for producing them and pharmaceutical compositions containing them
HUP0303347A3 (en) Omega-aminoalkylamides of r-2-aryl-propionic acids as inhibitors of the chemotaxis polymorphonucleate and mononucleate cells, process for their preparation and pharmaceutical compositions containing them
TW200505837A (en) Novel compounds
IL170834A (en) Imidazo-pyridine derivatives and their use as medicaments
DE60327066D1 (de) Saure protein- und ballaststoffhaltige zusammensetzungen und verfahren zu ihrer herstellung
DE602004024213D1 (en) Aminopropanolderivate
MY147262A (en) 1-aza-bicyclo[3.3.1]nonanes
TW200510344A (en) Aryl-heteroaromatic products, compositions comprising them and use
DE602005023755D1 (de) Indolonderivate, verfahren zu deren herstellung und deren anwendungen
ATE424384T1 (de) Imidazolderivate, verfahren zu deren herstellung und deren anwendungen
ATE323092T1 (de) Pyridopyrimidinon-derivate, verfahren zu ihrer herstellung und diese enthaltende pharmazeutische zusammensetzungen
DE602005002647D1 (de) Hexensäurederivate, verfahren zu deren herstellung, pharmazeutische zusammensetzungen, die diese enthalten, und therapeutische anwendungen davon
AU2003231920A8 (en) Antiinfectve compounds, process for their preparation and pharmaceutical compositions containing them
ATE503749T1 (de) Buttersäurederivate, verfahren zu deren herstellung, pharmazeutische zusammensetzungen, die diese enthalten, und therapeutische anwendungen davon
ATE452120T1 (de) Fettsäure-benzenediol-derivate sowie herstellungs-und verwendungsverfahren dafür
HUP0401525A2 (en) Kynurenic acid amide derivatives, pharmaceutical compositions containing them and process for producing them
ATE381338T1 (de) Benzothiadiazinderivate, verfahren zu deren herstellung und pharmazeutische zusammensetzungen,die diese enthalten
ATE250578T1 (de) Indenoindolon-derivate, verfahren zu ihrer herstellung und die enthaltenden pharmazeutischen zusammensetzungen
ATE248171T1 (de) Isoindoloindolon-derivate, verfahren zu ihrer herstellung und die enthaltende pharmazeutische zusammensetzungen